Reducing Antibiotic Use

Reducing Antibiotic Use – 22nd November, 2016

Managing Director of AFT Pharmaceuticals, Dr Hartley Atkinson, says that the pharmaceutical industry needs to take a leading role in helping reduce antibiotic use.

Following on from the World Health Organisation’s antibiotics awareness campaign, this week a New Zealand online discussion begins about the misuse of antibiotics in this country called InfectedNZ.

Healthcare professionals and political leaders continue to sound warnings that the overuse of antibiotics presents a serious danger to human health. “The threat of untreatable infections is real,” says Arjun Srinivasan MD from the US Centres for Disease Control and Prevention. “Although previously unthinkable, the day when antibiotics don’t work is upon us. We are already seeing germs that are stronger than any antibiotics we have to treat them.”

Overuse allows bacteria to develop resistance to antibiotics, thereby rendering them less effective. This means that people’s ability to recover from routine infections is becoming increasingly compromised.

New Zealand’s use of antibiotics is considered excessive by medical professionals.

Dr Mark Thomas from the University of Auckland has noted that antibiotic consumption has risen rapidly in New Zealand in recent years. According to Dr Thomas, “New Zealand is awash with antibiotics. Each year, per head of population, we swallow more antibiotic syrups and pills, and smear more antibiotic creams on our skin, than people in most similar developed countries.”

 Researchers have pointed to a link between the overuse of topical antibiotics, especially among children, and multi-drug resistant (MRSA) strains of the common infection staphylococcus aureus. Dr Deborah Williamson of Otago University says that “our current use of topical antibiotics is endangering our antibiotic supply and putting lives at risk.”
Managing Director of AFT Pharmaceuticals, Dr Hartley Atkinson, supports the view that the only way to significantly reduce antibiotic use is through joint action between pharmaceutical companies, medical professionals, and consumers.
No Comments

Sorry, the comment form is closed at this time.